HLA-DRB1*15 and pediatric aplastic anemia

    Research output: Contribution to journalArticlepeer-review

    Abstract

    We report a positive association between HLA-DRB1*15 (p= 0.0002) in Turkish patients with pediatric severe aplastic anemia (SAA) and a paradoxically favorable influence of the susceptibility marker on the clinical response to immunosuppressive therapy. These findings point to an immune mechanism mediated by DRB1*15 in SAA which confers responsiveness to treatment.
    Original languageEnglish
    Pages (from-to)772-774
    JournalHaematologica
    Volume87
    Issue number7
    Publication statusPublished - 2002

    Keywords

    • Biological sciences

    Fingerprint

    Dive into the research topics of 'HLA-DRB1*15 and pediatric aplastic anemia'. Together they form a unique fingerprint.

    Cite this